{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T07:45:07Z","timestamp":1771487107036,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The increased survival provided by the access, development, and evolution of antiretroviral drugs (ARV) greatly increased the life expectancy of people living with HIV (PWH). This has also led to an increased occurrence of diseases or morbidities related to aging. In individuals with multiple comorbidities, the simultaneous use of multiple medications, also known as polypharmacy, is common, and rational use of medications is essential. This study aims to describe the pharmacotherapeutic profile, estimate the prevalence of polypharmacy and identify factors associated with polypharmacy in a cohort of adult PWH from a referral unit in Rio de Janeiro, Brazil.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Cross-sectional study including PWH on ARV who received at least one medical prescription (outpatient\/hospitalized) in 2019. We described the proportion of prescribed medications according to ARV and Anatomical Therapeutic Chemical (ATC) classes stratified by age (&lt;\u200950 vs. \u226550 years). Polypharmacy was defined as \u2265\u20095 medications prescribed beyond ARV. Logistic regression models assessed demographic and clinical factors associated with polypharmacy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 143,306 prescriptions of 4547 PWH were analyzed. Median age was 44.4 years (IQR:35.4\u201354.1) and 1615 (35.6%) were \u2265\u200950 years. A total of 2958 (65.1%) participants self-identified as cisgender man, 1365 (30.0%) as cisgender woman, and 224 (4.9%) as transgender women. Most self-declared Black\/<jats:italic>Pardo<\/jats:italic> (2582; 65.1%) and 1984 (44.0%) completed elementary education or less. Median time since HIV diagnosis was 10.9 years (IQR:6.2\u201317.7). Most frequently prescribed concomitant medications were nervous system (64.8%), antiinfectives for systemic use (60.0%), alimentary tract and metabolism (45.9%), cardiovascular system (40.0%) and respiratory system (37.1%). Prevalence of polypharmacy was 50.6% (95%CI: 49.2\u201352.1). Model results indicated that being older, self-identify as cisgender woman, having less education and longer time since HIV diagnosis increased the odds of polypharmacy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We found high rates of polypharmacy and concomitant medication use in a cohort of PWH in Brazil. Targeted interventions should be prioritized to prevent interactions and improve treatment, especially among individuals using central nervous system and cardiovascular medications, as well as certain groups such as cisgender women, older individuals and those with lower education. Standardized protocols for continuous review of patients\u2019 therapeutic regimens should be implemented.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12981-023-00548-6","type":"journal-article","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T07:02:04Z","timestamp":1692601324000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pharmacotherapeutic profile, polypharmacy and its associated factors in a cohort of people living with HIV in Brazil"],"prefix":"10.1186","volume":"20","author":[{"given":"Robson Pierre Nascimento","family":"da Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luana M. S.","family":"Marins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lusiele","family":"Guaraldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula Mendes","family":"Luz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra W.","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronaldo I.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa da Gama","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valdilea G.","family":"Veloso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Grinsztejn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Estrela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thiago S.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,21]]},"reference":[{"key":"548_CR1","unstructured":"UNAIDS, Global HIV. & AIDS statistics \u2014 Fact sheet [Internet]. 2022 [cited 2023 May 30]. Available from: https:\/\/www.unaids.org\/en\/resources\/fact-sheet."},{"key":"548_CR2","unstructured":"Minist\u00e9rio da Sa\u00fade, Departamento de Doen\u00e7as de Condi\u00e7\u00f5es Cr\u00f4nicas e Infec\u00e7\u00f5es Sexualmente Transmiss\u00edveis. Boletim Epidemiol\u00f3gico HIV\/Aids 2021 [Internet]. Bras\u00edlia\/DF: Minist\u00e9rio da Sa\u00fade. ; 2021 Dec. Available from: http:\/\/www.aids.gov.br\/pt-br\/pub\/2021\/boletim-epidemiologico-hivaids-2021."},{"key":"548_CR3","unstructured":"Santos GS. dos. Monitoramento imunol\u00f3gico na hist\u00f3ria da infec\u00e7\u00e3o pelo HIV-1 [Internet]. [S\u00e3o Paulo]: Sec. Est. Sa\u00fade SP; 2019 [cited 2020 May 27]. Available from: http:\/\/docs.bvsalud.org\/biblioref\/2019\/08\/1010326\/tcc-graziele-santos-2019.pdf."},{"key":"548_CR4","unstructured":"Brazil, Ministry of Health. Preven\u00e7\u00e3o Combinada [Internet]. 2022 [cited 2022 Jun 24]. Available from: http:\/\/www.aids.gov.br\/pt-br\/publico-geral\/previna-se."},{"key":"548_CR5","doi-asserted-by":"publisher","first-page":"100573","DOI":"10.1016\/j.eclinm.2020.100573","volume":"28","author":"S Kanters","year":"2020","unstructured":"Kanters S, Vitoria M, Zoratti M, Doherty M, Penazzato M, Rangaraj A, et al. Comparative efficacy, tolerability and safety of dolutegravir and efavirenz 400\u00a0mg among antiretroviral therapies for first-line HIV treatment: a systematic literature review and network meta-analysis. EClinicalMedicine. 2020;28:100573.","journal-title":"EClinicalMedicine"},{"key":"548_CR6","doi-asserted-by":"publisher","first-page":"e266","DOI":"10.1016\/S2352-3018(20)30358-1","volume":"8","author":"CL Smiley","year":"2021","unstructured":"Smiley CL, Rebeiro PF, Cesar C, Belaunzaran-Zamudio PF, Crabtree-Ramirez B, Padgett D, et al. Estimated life expectancy gains with antiretroviral therapy among adults with HIV in Latin America and the Caribbean: a multisite retrospective cohort study. Lancet HIV. 2021;8:e266\u201373.","journal-title":"Lancet HIV"},{"key":"548_CR7","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1093\/cid\/ciu869","volume":"60","author":"KN Althoff","year":"2015","unstructured":"Althoff KN, McGinnis KA, Wyatt CM, Freiberg MS, Gilbert C, Oursler KK, et al. Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and Non-AIDS-Defining Cancer in HIV-Infected Versus Uninfected adults. Clin Infect Dis. 2015;60:627\u201338.","journal-title":"Clin Infect Dis"},{"key":"548_CR8","first-page":"464","volume":"17","author":"SW Cardoso","year":"2013","unstructured":"Cardoso SW, Torres TS, Santini-Oliveira M, Marins LMS, Veloso VG, Grinsztejn B. Aging with HIV: a practical review. Braz J Infect Dis Off Publ Braz Soc Infect Dis. 2013;17:464\u201379.","journal-title":"Braz J Infect Dis Off Publ Braz Soc Infect Dis"},{"key":"548_CR9","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1093\/cid\/cir627","volume":"53","author":"G Guaraldi","year":"2011","unstructured":"Guaraldi G, Orlando G, Zona S, Menozzi M, Carli F, Garlassi E, et al. Premature age-related Comorbidities among HIV-Infected persons compared with the General Population. Clin Infect Dis. 2011;53:1120\u20136.","journal-title":"Clin Infect Dis"},{"key":"548_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/QAD.0000000000002063","volume":"33","author":"D De Francesco","year":"2019","unstructured":"De Francesco D, Wit FW, B\u00fcrkle A, Oehlke S, Kootstra NA, Winston A, et al. Do people living with HIV experience greater age advancement than their HIV-negative counterparts? AIDS. 2019;33:259\u201368.","journal-title":"AIDS"},{"key":"548_CR11","doi-asserted-by":"publisher","first-page":"146446","DOI":"10.1016\/j.brainres.2019.146446","volume":"1724","author":"M-L Guo","year":"2019","unstructured":"Guo M-L, Buch S. Neuroinflammation & pre-mature aging in the context of chronic HIV infection and drug abuse: role of dysregulated autophagy. Brain Res. 2019;1724:146446.","journal-title":"Brain Res"},{"key":"548_CR12","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1590\/1413-81232021264.08472019","volume":"26","author":"PC de Oliveira","year":"2021","unstructured":"de Oliveira PC, Silveira MR, Ceccato M, das GB, Reis AMM, Pinto IVL, Reis EA. Preval\u00eancia e Fatores Associados \u00e0 Polifarm\u00e1cia em Idosos Atendidos na Aten\u00e7\u00e3o Prim\u00e1ria \u00e0 Sa\u00fade em Belo Horizonte-MG, Brasil. Ci\u00eanc Sa\u00fade Coletiva. 2021;26:1553\u201364.","journal-title":"Ci\u00eanc Sa\u00fade Coletiva"},{"key":"548_CR13","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.medcli.2012.01.017","volume":"139","author":"I Vallejo Maroto","year":"2012","unstructured":"Vallejo Maroto I, Fern\u00e1ndez Moyano A. Continuidad asistencial en el paciente pluripatol\u00f3gico. Med Cl\u00ednica. 2012;139:206\u20137.","journal-title":"Med Cl\u00ednica"},{"key":"548_CR14","doi-asserted-by":"publisher","first-page":"142","DOI":"10.25100\/cm.v50i3.4128","volume":"50","author":"S Fern\u00e1ndez Ca\u00f1abate","year":"2019","unstructured":"Fern\u00e1ndez Ca\u00f1abate S, Ortega Val\u00edn L. Polypharmacy among HIV infected people aged 50 years or older. Colomb Med Cali Colomb. 2019;50:142\u201352.","journal-title":"Colomb Med Cali Colomb"},{"key":"548_CR15","doi-asserted-by":"publisher","first-page":"E22","DOI":"10.5888\/pcd17.190359","volume":"17","author":"C Okoli","year":"2020","unstructured":"Okoli C, de Los Rios P, Eremin A, Brough G, Young B, Short D. Relationship between polypharmacy and quality of life among people in 24 countries living with HIV. Prev Chronic Dis. 2020;17:E22.","journal-title":"Prev Chronic Dis"},{"key":"548_CR16","doi-asserted-by":"crossref","unstructured":"Pontelo BM, Greco DB, Guimar\u00e3es NS, Rotsen N, Braga VAR, Pimentel PHN et al. Profile of drug\u2013drug interactions and impact on the effectiveness of antiretroviral therapy among patients living with HIV followed at an infectious Diseases Referral Center in Belo Horizonte, Brazil. Braz J Infect Dis. 2020;S1413867020300301.","DOI":"10.1016\/j.bjid.2020.03.006"},{"key":"548_CR17","unstructured":"WHOCC - ATC\/DDD Index [Internet]. [cited 2021 May 26]. Available from: https:\/\/www.whocc.no\/atc_ddd_index\/."},{"key":"548_CR18","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Centeno B, Badenes-Olmedo C, Mataix-Sanjuan \u00c1, Mcallister K, Bell\u00f3n JM, Gibbons S et al. Polypharmacy and Drug\u2013Drug Interactions in People Living With Human Immunodeficiency Virus in the Region of Madrid, Spain: A Population-Based Study. Clin Infect Dis. 2019;ciz811.","DOI":"10.1093\/cid\/ciz811"},{"key":"548_CR19","unstructured":"IBGE. Cor ou ra\u00e7a | Educa | Jovens - IBGE [Internet]. [cited 2022 Jan 5]. Available from: https:\/\/educa.ibge.gov.br\/jovens\/conheca-o-brasil\/populacao\/18319-cor-ou-raca.html."},{"key":"548_CR20","unstructured":"R: The R Project for Statistical Computing [Internet]. [cited 2021 May 26]. Available from: https:\/\/www.r-project.org\/."},{"key":"548_CR21","unstructured":"PROTOCOLO CL\u00cdNICO E DIRETRIZES TERAP\u00caUTICAS PARA PROFILAXIA P\u00d3S-EXPOSI\u00c7\u00c3O PEP DE RISCO \u00c0 INFEC\u00c7\u00c3O PELO HIV, IST E HEPATITES VIRAIS. | Departamento de Doen\u00e7as de Condi\u00e7\u00f5es Cr\u00f4nicas e Infec\u00e7\u00f5es Sexualmente Transmiss\u00edveis [Internet]. [cited 2022 Jan 5]. Available from: http:\/\/www.aids.gov.br\/pt-br\/pub\/2021\/protocolo-clinico-e-diretrizes-terapeuticas-para-profilaxia-pos-exposicao-pep-de-risco."},{"key":"548_CR22","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.bjid.2012.10.024","volume":"17","author":"TS Torres","year":"2013","unstructured":"Torres TS, Cardoso SW, Velasque L, de Marins S, de Oliveira LMS, Veloso MS. Aging with HIV: an overview of an urban cohort in Rio de Janeiro (Brazil) across decades of life. Braz J Infect Dis. 2013;17:324\u201331.","journal-title":"Braz J Infect Dis"},{"key":"548_CR23","doi-asserted-by":"publisher","first-page":"e269","DOI":"10.1016\/S2352-3018(22)00003-0","volume":"9","author":"AC Justice","year":"2022","unstructured":"Justice AC, Goetz MB, Stewart CN, Hogan BC, Humes E, Luz PM, et al. Delayed presentation of HIV among older individuals: a growing problem. Lancet HIV. 2022;9:e269\u201380.","journal-title":"Lancet HIV"},{"key":"548_CR24","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2174\/1568006054553444","volume":"5","author":"G Barbaro","year":"2005","unstructured":"Barbaro G. Reviewing the cardiovascular complications of HIV infection after the introduction of highly active antiretroviral therapy. Curr Drug Targets Cardiovasc Haematol Disord. 2005;5:337\u201343.","journal-title":"Curr Drug Targets Cardiovasc Haematol Disord"},{"key":"548_CR25","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1590\/S0104-42302010000200027","volume":"56","author":"PP Christo","year":"2010","unstructured":"Christo PP. Altera\u00e7\u00f5es cognitivas na infec\u00e7\u00e3o pelo HIV e Aids. Rev Assoc M\u00e9dica Bras. 2010;56:242\u20137.","journal-title":"Rev Assoc M\u00e9dica Bras"},{"key":"548_CR26","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1097\/QAI.0000000000000606","volume":"69","author":"N Ford","year":"2015","unstructured":"Ford N, Shubber Z, Pozniak A, Vitoria M, Doherty M, Kirby C, et al. Comparative safety and neuropsychiatric adverse events Associated with Efavirenz Use in First-Line antiretroviral therapy: a systematic review and Meta-analysis of Randomized trials. JAIDS J Acquir Immune Defic Syndr. 2015;69:422\u20139.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"548_CR27","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s11904-019-00426-9","volume":"16","author":"R Paul","year":"2019","unstructured":"Paul R. Neurocognitive phenotyping of HIV in the era of antiretroviral therapy. Curr HIV\/AIDS Rep. 2019;16:230\u20135.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"548_CR28","doi-asserted-by":"publisher","first-page":"641913","DOI":"10.1155\/2015\/641913","volume":"2015","author":"EM Tedaldi","year":"2015","unstructured":"Tedaldi EM, Minniti NL, Fischer T. HIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbidities. BioMed Res Int. 2015;2015:641913.","journal-title":"BioMed Res Int"},{"key":"548_CR29","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s11904-021-00583-w","volume":"18","author":"J Hoare","year":"2021","unstructured":"Hoare J, Sevenoaks T, Mtukushe B, Williams T, Heany S, Phillips N. Global systematic review of common Mental Health Disorders in adults living with HIV. Curr HIV\/AIDS Rep. 2021;18:569\u201380.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"548_CR30","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3851\/IMP3293","volume":"24","author":"M O Halloran","year":"2019","unstructured":"O Halloran M, Boyle C, Kehoe B, Bagkeris E, Mallon P, Post FA, et al. Polypharmacy and drug\u2013drug interactions in older and younger people living with HIV: the POPPY study. Antivir Ther. 2019;24:193\u2013201.","journal-title":"Antivir Ther"},{"key":"548_CR31","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3851\/IMP1540","volume":"15","author":"C Marzolini","year":"2010","unstructured":"Marzolini C, Elzi L, Gibbons S, Weber R, Fux C, Furrer H, et al. Prevalence of comedications and effect of potential drug\u2013drug interactions in the swiss HIV Cohort Study. Antivir Ther. 2010;15:413\u201323.","journal-title":"Antivir Ther"},{"key":"548_CR32","doi-asserted-by":"publisher","first-page":"ofz531","DOI":"10.1093\/ofid\/ofz531","volume":"6","author":"P Courlet","year":"2019","unstructured":"Courlet P, Livio F, Guidi M, Cavassini M, Battegay M, Stoeckle M, et al. Polypharmacy, drug\u2013drug interactions, and inappropriate drugs: New Challenges in the Aging Population with HIV. Open Forum Infect Dis. 2019;6:ofz531.","journal-title":"Open Forum Infect Dis"},{"key":"548_CR33","doi-asserted-by":"crossref","unstructured":"Lima MAC, Cunha GH da, Galv\u00e3o MTG, Rocha RP, Franco KB, Fontenele MSM et al. Hipertens\u00e3o arterial sist\u00eamica em pessoas vivendo com HIV\/aids: revis\u00e3o integrativa. Rev Bras Enferm. 2017;70:1309\u201317.","DOI":"10.1590\/0034-7167-2016-0416"},{"key":"548_CR34","doi-asserted-by":"publisher","first-page":"e013466","DOI":"10.1161\/JAHA.119.013466","volume":"9","author":"G Vos Alinda","year":"2020","unstructured":"Vos Alinda G, Barth Roos E, Klipstein-Grobusch Kerstin, Tempelman Hugo A, Devill\u00e9 Walter LJ, Caitlin D, et al. Cardiovascular Disease Burden in Rural Africa: does HIV and Antiretroviral Treatment play a role? J Am Heart Assoc. 2020;9:e013466.","journal-title":"J Am Heart Assoc"},{"key":"548_CR35","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/IPC.0b013e3181f1038b","volume":"18","author":"NF Crum-Cianflone","year":"2010","unstructured":"Crum-Cianflone NF. Human immunodeficiency virus and the gastrointestinal tract. Infect Dis Clin Pract. 2010;18:283\u20135.","journal-title":"Infect Dis Clin Pract"},{"key":"548_CR36","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1590\/S0037-86822009000500013","volume":"42","author":"\u00c1RT Pupulin","year":"2009","unstructured":"Pupulin \u00c1RT, Carvalho PG, Nishi L, Nakamura CV, Guilherme ALF. Enteropat\u00f3genos relacionados \u00e0 diarr\u00e9ia em pacientes HIV que fazem uso de terapia anti-retroviral. Rev Soc Bras Med Trop. 2009;42:551\u20135.","journal-title":"Rev Soc Bras Med Trop"},{"key":"548_CR37","doi-asserted-by":"publisher","first-page":"e98666","DOI":"10.1371\/journal.pone.0098666","volume":"9","author":"L Coelho","year":"2014","unstructured":"Coelho L, Cardoso SW, Amancio RT, Moreira RI, Campos DP, Veloso VG, et al. Trends in AIDS-defining opportunistic illnesses incidence over 25 years in Rio de Janeiro, Brazil. PLoS ONE. 2014;9:e98666.","journal-title":"PLoS ONE"},{"key":"548_CR38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/QAD.0000000000001685","volume":"32","author":"KJ Siefried","year":"2018","unstructured":"Siefried KJ, Mao L, Cysique LA, Rule J, Giles ML, Smith DE, et al. Concomitant medication polypharmacy, interactions and imperfect adherence are common in australian adults on suppressive antiretroviral therapy. AIDS. 2018;32:35\u201348.","journal-title":"AIDS"},{"key":"548_CR39","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.3389\/fimmu.2019.02531","volume":"10","author":"J Zhao","year":"2019","unstructured":"Zhao J, Nguyen LNT, Nguyen LN, Dang X, Cao D, Khanal S, et al. ATM Deficiency accelerates DNA damage, Telomere Erosion, and premature T cell aging in HIV-Infected individuals on antiretroviral therapy. Front Immunol. 2019;10:2531.","journal-title":"Front Immunol"},{"key":"548_CR40","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1002\/phar.2043","volume":"37","author":"IR McNicholl","year":"2017","unstructured":"McNicholl IR, Gandhi M, Hare CB, Greene M, Pierluissi E. A pharmacist-led program to evaluate and reduce polypharmacy and potentially inappropriate prescribing in older HIV-Positive patients. Pharmacother J Hum Pharmacol Drug Ther. 2017;37:1498\u2013506.","journal-title":"Pharmacother J Hum Pharmacol Drug Ther"},{"key":"548_CR41","doi-asserted-by":"publisher","first-page":"121","DOI":"10.5123\/S1679-49742017000100013","volume":"26","author":"AS Sales","year":"2017","unstructured":"Sales AS, Sales MGS, Casotti CA. Perfil farmacoterap\u00eautico e fatores associados \u00e0 polifarm\u00e1cia entre idosos de aiquara, Bahia, em 2014*. Epidemiol E Servi\u00e7os Sa\u00fade. 2017;26:121\u201332.","journal-title":"Epidemiol E Servi\u00e7os Sa\u00fade"},{"key":"548_CR42","doi-asserted-by":"publisher","first-page":"e002378","DOI":"10.1136\/bmjopen-2012-002378","volume":"3","author":"D Loikas","year":"2013","unstructured":"Loikas D, Wettermark B, von Euler M, Bergman U, Schenck-Gustafsson K. Differences in drug utilisation between men and women: a cross-sectional analysis of all dispensed drugs in Sweden. BMJ Open. 2013;3:e002378.","journal-title":"BMJ Open"},{"key":"548_CR43","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1089\/jwh.2012.3972","volume":"23","author":"M Manteuffel","year":"2014","unstructured":"Manteuffel M, Williams S, Chen W, Verbrugge RR, Pittman DG, Steinkellner A. Influence of patient sex and gender on Medication Use, Adherence, and prescribing alignment with guidelines. J Womens Health. 2014;23:112\u20139.","journal-title":"J Womens Health"},{"key":"548_CR44","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3389\/fphar.2020.00326","volume":"11","author":"N Zhang","year":"2020","unstructured":"Zhang N, Sundquist J, Sundquist K, Ji J. An increasing Trend in the prevalence of polypharmacy in Sweden: a Nationwide Register-Based study. Front Pharmacol. 2020;11:326.","journal-title":"Front Pharmacol"},{"key":"548_CR45","doi-asserted-by":"crossref","unstructured":"Silva IR, Giatti L, Chor D, Fonseca M, de Mengue JM, de Acurcio SS et al. A,. Polypharmacy, socioeconomic indicators and number of diseases: results from ELSA-Brasil. Rev Bras Epidemiol. 2020;23:e200077.","DOI":"10.1590\/1980-549720200077"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-023-00548-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-023-00548-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-023-00548-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T14:07:14Z","timestamp":1700489234000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-023-00548-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,21]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["548"],"URL":"https:\/\/doi.org\/10.1186\/s12981-023-00548-6","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,21]]},"assertion":[{"value":"19 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been approved by the INI\/Fiocruz Institutional Review Board (CAAE 33386720.5.0000.5262).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"57"}}